Cargando…

Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma

BACKGROUND: Lung squamous cell carcinoma (LUSC) generally correlates with poor clinical prognoses due to the lack of available prognostic biomarkers. This study is designed to identify a potential biomarker significant for the prognosis and treatment of LUSC, so as to provide a scientific basis for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Cailian, Gu, Xuyu, Zhang, Xiuxiu, Zhou, Min, Chen, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569707/ https://www.ncbi.nlm.nih.gov/pubmed/34745990 http://dx.doi.org/10.3389/fonc.2021.756096

Ejemplares similares

Development and Validation of a DNA Methylation-related Classifier of Circulating Tumour Cells to Predict Prognosis and to provide a therapeutic strategy in Lung Adenocarcinoma
por: Gu, Xuyu, et al.
Publicado: (2022)

Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer
por: Zhou, Min, et al.
Publicado: (2022)

Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma
por: Hou, Chen, et al.
Publicado: (2020)

Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data
por: Cui, Yishuang, et al.
Publicado: (2023)

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
por: Weng, Chengyin, et al.
Publicado: (2021)

Development and validation of a novel fibroblast scoring model for lung adenocarcinoma
por: Wei, Shiyou, et al.
Publicado: (2022)

High Expression of TACC3 Is Associated with the Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma Patients
por: Chen, Yan, et al.
Publicado: (2022)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
por: Wang, Shuqin, et al.
Publicado: (2022)

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma
por: Chen, Yang, et al.
Publicado: (2023)

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma
por: Chen, Yongwei, et al.
Publicado: (2023)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma
por: He, Shujiao, et al.
Publicado: (2022)

Construction of a DDR-related signature for predicting of prognosis in metastatic colorectal carcinoma
por: Wei, Maohua, et al.
Publicado: (2023)

Prognostic Value of an Immune-Related Gene Signature in Oral Squamous Cell Carcinoma
por: Zhu, Chao, et al.
Publicado: (2021)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma
por: Xu, Peipei, et al.
Publicado: (2023)

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
por: Zhang, Jun-Song, et al.
Publicado: (2023)

Establishment and validation of a ferroptosis-related signature predicting prognosis and immunotherapy effect in colon cancer
por: Li, Zhufeng, et al.
Publicado: (2023)

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Ze-Kun, et al.
Publicado: (2022)

Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma
por: Peng, Jie, et al.
Publicado: (2022)

Ferroptosis-related gene signature predicts prognosis in kidney renal papillary cell carcinoma
por: Yin, Haiying, et al.
Publicado: (2022)

A macropinocytosis-related gene signature predicts the prognosis and immune microenvironment in hepatocellular carcinoma
por: Ding, Xinjiang, et al.
Publicado: (2023)

Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma
por: Pan, Jingxin, et al.
Publicado: (2020)

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Weiyu, et al.
Publicado: (2022)

Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
por: Cui, Heyang, et al.
Publicado: (2021)

A Five-MicroRNA Signature Predicts the Prognosis in Nasopharyngeal Carcinoma
por: Wu, Shixiong, et al.
Publicado: (2021)

A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma
por: Su, Lisa, et al.
Publicado: (2021)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

Development and validation of a CECT-based radiomics model for predicting IL1B expression and prognosis of head and neck squamous cell carcinoma
por: Xie, Yang, et al.
Publicado: (2023)

Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020)

Hippo Pathway Core Genes Based Prognostic Signature and Immune Infiltration Patterns in Lung Squamous Cell Carcinoma
por: Gu, Chang, et al.
Publicado: (2021)

Immune‐related eight‐lncRNA signature for improving prognosis prediction of lung adenocarcinoma
por: Chen, Yan, et al.
Publicado: (2021)

Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma
por: Fu, Denggang, et al.
Publicado: (2020)

A Cell Cycle-Related 13-mRNA Signature to Predict Prognosis in Hepatocellular Carcinoma
por: Zhou, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ebudvho2ksa3p0cgsb5knu8hfi